| Literature DB >> 19292733 |
Peter Boor1, Sandra Casper, Peter Celec, Marta Hurbánková, Milan Beno, August Heidland, Kerstin Amann, Katarína Sebeková.
Abstract
Passive smoking is an independent risk factor for cardiovascular diseases. Industrial fibrous dust, e.g. the asbestos group member, amosite, causes lung cancer and fibrosis. No data are available on renal involvement after inhalational exposure to these environmental pollutants or of their combination, or on cardiovascular and renal toxicity after exposure to amosite. Male Wistar rats were randomized into four groups (n= 6): control and amosite group received initially two intratracheal instillations of saline and amosite solution, respectively. Smoking group was subjected to standardized daily exposure to tobacco smoke for 2 hrs in a concentration resembling human passive smoking. Combined group was exposed to both amosite and cigarette smoke. All rats were killed after 6 months. Rats exposed to either amosite or passive smoking developed significant glomerulosclerosis and tubulointerstitial fibrosis. Combination of both exposures had additive effects. Histomorphological changes preceded the clinical manifestation of kidney damage. In both groups with single exposures, marked perivascular and interstitial cardiac fibrosis was detected. The additive effect in the heart was less pronounced than in the kidney, apparent particularly in changes of vascular structure. Advanced oxidation protein products, the plasma marker of the myeloperoxidase reaction in activated monocytes/macrophages, were increased in all exposed groups, whereas the inflammatory cytokines did not differ between the groups. In rats, passive smoking or amosite instillation leads to renal, vascular and cardiac fibrosis potentially mediated via increased myeloperoxidase reaction. Combination of both pollutants shows additive effects. Our data should be confirmed in subjects exposed to these environmental pollutants, in particular if combined.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19292733 PMCID: PMC4515064 DOI: 10.1111/j.1582-4934.2008.00518.x
Source DB: PubMed Journal: J Cell Mol Med ISSN: 1582-1838 Impact factor: 5.310
Primers used in this study for gene expression analysis using real time PCR
| Gene / Gene ID | Forward primer | Reverse primer |
|---|---|---|
| ppia / 25518 | gtctcttttcgccgcttgct | tctgctgtctttggaactttgtctg |
| col1a1 / 29393 | caacctcaagaagtccctgc | acaagcgtgctgtaggtgaa |
| fn1 / 25661 | caaggtccgagaagaggttg | ccgtgtaagggtcaaagcat |
| il6 / 24498 | accaggaacgaaagtcaactcc | ttgtgaagtagggaaggcagt |
| nephrin / 64563 | ctaaggatgggctgcttctg | gtggaactcgcctttagcac |
| sod2 / 24787 | ccaaaggagagttgctggag | gaaccttggactcccacaga |
| tgfb1 / 59086 | gaaggacctgggttggaagt | tactgtgtgtccaggctcca |
| tnfa / 24835 | atccgagatgtggaactggc | tcagtagacagaagagcgtggtg |
| mpo / 303413 | ggaagtggcgaactcagtgg | aggagttccatagggctggc |
ppia, peptidylprolyl isomerase A (cyclophilin A)
col1a1, collagen type I alpha 1 chain
fn1, fibronectin
il6, interleukin 6
sod2, superoxide dismutase 2
tgfb1, transforming growth factor beta 1
tnfa, tumour necrosis factor alpha
mpo, myeloperoxidase.
Functional parameter, blood pressure and biochemical measurements
| Control ( | Amosite ( | Smoke ( | Combination ( | |
|---|---|---|---|---|
| Body weight [g] | 658 ± 92 | 698 ± 63 | 593 ± 44 | 595 ± 54 |
| Kidney weight [g] | 3.7 ± 0.6 | 4.0 ± 0.7 | 3.5 ± 0.4 | 3.3 ± 0.3 |
| SBP [mmHg] | 102 ± 5 | 101 ± 10 | 101 ± 4 | 103 ± 7 |
| SBP/BW [mmHg/100 g] | 15.7 ± 2.3 | 14.5 ± 1.4 | 17.1 ± 1.5 | 17.4 ± 2.1 |
| P-Crea [μmol/l] | 56 ± 8 | 62 ± 8 | 63 ± 9 | 63 ± 11 |
| Clcrea[μ/min/100 g] | 293 ± 95 | 272 ± 140 | 351 ± 69 | 319 ± 71 |
| P-Urea [mmol/l] | 4.6±0.7 | 5.2±1.0 | 5.0±0.7 | 5.1±0.6 |
| Diuresis [ml/24 hrs] | 15 ± 5 | 22 ± 9 | 16 ± 6 | 15 ± 8 |
| Proteinuria [mg/24 hrs] | 6.9 ± 5.6 | 7.9 ± 4.9 | 4.4 ± 0.8 | 5.4 ± 3.0 |
| AOPPs [μmol/l] |
BW, body weight
SBP, systolic blood pressure
P, plasma
Crea, creatinine
Cl, clearance
AOPPs, advanced oxidation protein products
P < 0.05 versus controls.
Figure 1Indices of renal damage: glomerulosclerosis (A), tubulointerstitial fibrosis (B) and thickness of renal vasculature (C). Representative pictures of renal cortical tubulointerstitium stained with Sirius red of control rats (D) or rats exposed to amosite (E), passive smoking (F) or combination of both (G). ctrl, control group; amos, amosite group; smoke, passive smoking group; combi, combination of amosite and passive smoking group. *P < 0.05 versus control, #P < 0.05 versus combination.
Figure 2Glomerular mRNA expression of fibronectin (A), SOD (B) and nephrin (C) and cortical tubulointerstitial mRNA expression of collagen type I (D), TGF-β1 (E) and SOD (F). mRNA was measured by RT-PCR, normalized to housekeeping gene peptidylprolyl isomerase A (cyclophilin A) and expressed as fold induction compared to control group, which was set as 1. *P < 0.05 versus control.
Figure 3Indices of cardiovascular damage: heart vessel wall thickness (A), aortic damage score (B) and heart interstitial (C) and perivascular (D) fibrosis scores. Representative pictures of the heart stained with Sirius red of control rats (E) or rats exposed to amosite (F), passive smoking (G) or combination thereof (H). ctrl, control group; amos, amosite group; smoke, passive smoking group; combi, combination of amosite and passive smoking group. *P < 0.05 versus control, #P < 0.05 versus combination.